We have shown that MTX is an effective, well-tolerated treatment for moderate-to-severe atopic eczema, and response appears to compare favourably with other second-line therapies. A randomized, controlled trial is now warranted.

No abstract

Many treatments for this chronic skin disease are harmful to the developing fetus, so careful pre-conception planning and management adjustment are crucial for the pregnant patient

No abstract

Many women with eczema experience flares during pregnancy, and management must take account of the possible effects of some treatments on the fetus

Ultraviolet B (UVB) is a highly effective, relatively safe, affordable and widely used therapeutic option for moderate psoriasis.

No abstract

Linked Comment: P. Wolf. Br J Dermatol 2022; 187:285–286.